199 related articles for article (PubMed ID: 12755957)
121. Identifying Thyroid Carcinoma-Related Genes by Integrating GWAS and eQTL Data.
Shen F; Gan X; Zhong R; Feng J; Chen Z; Guo M; Li Y; Wu Z; Cai W; Xu B
Front Cell Dev Biol; 2021; 9():645275. PubMed ID: 33614667
[TBL] [Abstract][Full Text] [Related]
122. Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review.
Chen L; Zhao K; Li F; He X
Front Oncol; 2020; 10():526716. PubMed ID: 33194586
[TBL] [Abstract][Full Text] [Related]
123. Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.
Khatami F; Tavangar SM
Biomark Insights; 2018; 13():1177271918785129. PubMed ID: 30013307
[TBL] [Abstract][Full Text] [Related]
124. Pediatric Medullary Thyroid Carcinoma.
Starenki D; Park JI
J Pediatr Oncol; 2015; 3(2):29-37. PubMed ID: 27014708
[TBL] [Abstract][Full Text] [Related]
125. Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.
Prokopakis E; Doulaptsi M; Kaprana A; Velegrakis S; Vlastos Y; Velegrakis G
Hippokratia; 2014 Apr; 18(2):130-4. PubMed ID: 25336875
[TBL] [Abstract][Full Text] [Related]
126. Is intraoperative calcitonin monitoring useful to modulate the extension of neck dissection in patients with medullary thyroid carcinoma?
De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
World J Surg; 2014 Mar; 38(3):568-75. PubMed ID: 24253105
[TBL] [Abstract][Full Text] [Related]
127. 10 rare tumors that warrant a genetics referral.
Banks KC; Moline JJ; Marvin ML; Newlin AC; Vogel KJ
Fam Cancer; 2013 Mar; 12(1):1-18. PubMed ID: 23377869
[TBL] [Abstract][Full Text] [Related]
128. Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.
Romei C; Pardi E; Cetani F; Elisei R
J Oncol; 2012; 2012():705036. PubMed ID: 23209466
[TBL] [Abstract][Full Text] [Related]
129. Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway.
Samadi AK; Bazzill J; Zhang X; Gallagher R; Zhang H; Gollapudi R; Kindscher K; Timmermann B; Cohen MS
Surgery; 2012 Dec; 152(6):1238-47. PubMed ID: 23158190
[TBL] [Abstract][Full Text] [Related]
130. Alternative surgical strategies in patients with sporadic medullary thyroid carcinoma: Long-term follow-up.
Ma SH; Liu QJ; Zhang YC; Yang R
Oncol Lett; 2011 Sep; 2(5):975-980. PubMed ID: 22866159
[TBL] [Abstract][Full Text] [Related]
131. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract][Full Text] [Related]
132. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
Ahmed SR; Ball DW
J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
[TBL] [Abstract][Full Text] [Related]
133. A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.
Samadi AK; Mukerji R; Shah A; Timmermann BN; Cohen MS
Surgery; 2010 Dec; 148(6):1228-36; discussion 1236. PubMed ID: 21134556
[TBL] [Abstract][Full Text] [Related]
134. Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases.
Brandão LG; Cavalheiro BG; Junqueira CR
Clinics (Sao Paulo); 2009; 64(9):849-56. PubMed ID: 19759878
[TBL] [Abstract][Full Text] [Related]
135. Parathyroid hormone-dependent hypercalcemia.
Toke J; Patócs A; Balogh K; Gergics P; Stenczer B; Rácz K; Tóth M
Wien Klin Wochenschr; 2009; 121(7-8):236-45. PubMed ID: 19562279
[TBL] [Abstract][Full Text] [Related]
136. Sporadic medullary thyroid carcinoma: clinical data from a university hospital.
Correia-Deur JE; Toledo RA; Imazawa AT; Lourenço DM; Ezabella MC; Tavares MR; Toledo SP
Clinics (Sao Paulo); 2009 May; 64(5):379-86. PubMed ID: 19488601
[TBL] [Abstract][Full Text] [Related]
137. Evidence-based approach to the management of sporadic medullary thyroid carcinoma.
Moley JF; Fialkowski EA
World J Surg; 2007 May; 31(5):946-56. PubMed ID: 17426901
[TBL] [Abstract][Full Text] [Related]
138. Multiple endocrine neoplasia type 2.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
[TBL] [Abstract][Full Text] [Related]
139. Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.
Scheuba C; Kaserer K; Kaczirek K; Asari R; Niederle B
World J Surg; 2006 May; 30(5):853-9. PubMed ID: 16680600
[TBL] [Abstract][Full Text] [Related]
140. Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study.
Erdogan MF; Gürsoy A; Ozgen G; Cakir M; Bayram F; Ersoy R; Algün E; Cetinarslan B; Cömlekçi A; Kadioglu P; Balci MK; Yetkin I; Kabalak T; Erdogan G
J Endocrinol Invest; 2005 Oct; 28(9):806-9. PubMed ID: 16370559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
